Your Search Returned 1 tagged news report
AVL-192 is an oral compound that silences the HCV protease (NS3) through irreversible covalent bonding to the target protein. Preclinical data presented by Avila demonstrated that it selectively inhibits drug-resistant mutations of HCV protease. AVL-
Tags: